Macquarie Group LTD Glaukos Corp Transaction History

Macquarie Group LTD

  • $80.3 Billion
  • Q1 2025

A detailed history of Macquarie Group LTD transactions in Glaukos Corp stock. As of the latest transaction made, Macquarie Group LTD holds 33,570 shares of GKOS stock, worth $3.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,570
Holding current value
$3.11 Million
% of portfolio
0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$96.6 - $161.22 $3.24 Million - $5.41 Million
33,570 New
33,570 $3.3 Million
Q3 2024

Nov 14, 2024
SELL
$113.62 - $135.39 $2 Million - $2.38 Million
-17,562 Reduced 31.77%
37,708 $4.91 Million
Q2 2024

Aug 09, 2024
SELL
$89.48 - $118.35 $189,697 - $250,902
-2,120 Reduced 3.69%
55,270 $6.54 Million
Q1 2024

May 14, 2024
SELL
$76.4 - $96.33 $107,036 - $134,958
-1,401 Reduced 2.38%
57,390 $5.41 Million
Q4 2023

Feb 14, 2024
SELL
$59.53 - $85.11 $3.3 Million - $4.72 Million
-55,421 Reduced 48.52%
58,791 $4.67 Million
Q3 2023

Nov 14, 2023
BUY
$69.23 - $79.09 $2.81 Million - $3.21 Million
40,532 Added 55.01%
114,212 $8.59 Million
Q2 2023

Aug 14, 2023
BUY
$45.44 - $71.21 $1.92 Million - $3 Million
42,169 Added 133.82%
73,680 $5.25 Million
Q1 2023

May 15, 2023
BUY
$43.88 - $52.48 $396,938 - $474,734
9,046 Added 40.27%
31,511 $1.58 Million
Q4 2022

Feb 21, 2023
BUY
$40.82 - $57.75 $900,244 - $1.27 Million
22,054 Added 5365.94%
22,465 $981,000
Q3 2022

Nov 14, 2022
SELL
$46.84 - $58.49 $9,602 - $11,990
-205 Reduced 33.28%
411 $70,000
Q3 2021

Nov 12, 2021
SELL
$47.43 - $84.23 $52.4 Million - $93.1 Million
-1,104,791 Reduced 99.94%
616 $30,000
Q2 2021

Aug 13, 2021
BUY
$73.06 - $97.7 $80.7 Million - $108 Million
1,104,242 Added 94784.72%
1,105,407 $93.8 Million
Q1 2021

May 14, 2021
SELL
$70.43 - $97.42 $25,213 - $34,876
-358 Reduced 23.51%
1,165 $98,000
Q2 2020

Aug 11, 2020
SELL
$28.78 - $46.83 $1.07 Million - $1.74 Million
-37,214 Reduced 96.07%
1,523 $59,000
Q1 2020

May 15, 2020
SELL
$25.53 - $70.14 $55,757 - $153,185
-2,184 Reduced 5.34%
38,737 $1.2 Million
Q4 2019

Feb 14, 2020
BUY
$54.18 - $65.64 $491,304 - $595,223
9,068 Added 28.47%
40,921 $2.23 Million
Q3 2019

Nov 14, 2019
BUY
$58.58 - $83.91 $609,056 - $872,412
10,397 Added 48.46%
31,853 $1.99 Million
Q2 2019

Aug 14, 2019
BUY
$63.59 - $78.71 $177,861 - $220,151
2,797 Added 14.99%
21,456 $1.62 Million
Q1 2019

May 15, 2019
SELL
$50.75 - $80.54 $168,236 - $266,990
-3,315 Reduced 15.09%
18,659 $1.46 Million
Q4 2018

Feb 15, 2019
BUY
$52.18 - $67.93 $169,793 - $221,044
3,254 Added 17.38%
21,974 $1.24 Million
Q3 2018

Nov 15, 2018
SELL
$38.13 - $68.37 $1.06 Million - $1.9 Million
-27,728 Reduced 59.7%
18,720 $1.22 Million
Q2 2018

Aug 14, 2018
BUY
$27.62 - $44.51 $17,069 - $27,507
618 Added 1.35%
46,448 $1.89 Million
Q1 2018

May 11, 2018
SELL
$26.05 - $34.5 $122,435 - $162,150
-4,700 Reduced 9.3%
45,830 $1.41 Million
Q4 2017

Feb 15, 2018
BUY
$24.5 - $36.01 $312,375 - $459,127
12,750 Added 33.75%
50,530 $1.3 Million
Q3 2017

Nov 08, 2017
BUY
$31.26 - $42.03 $1.18 Million - $1.59 Million
37,780
37,780 $1.25 Million

Others Institutions Holding GKOS

# of Institutions
358
Shares Held
50.2M
Call Options Held
260K
Put Options Held
776K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.41B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email